Determining the molecular basis and therapeutic potential of hyperactive stem cell programs in colorectal cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2110383
Recipient
Awarding agency
Obligated
$1,363,356

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded a $1,363,356 project grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) to determine the molecular basis and therapeutic potential of hyperactive stem cell programs in colorectal cancer. This funding supports the Military Medical Research and Development program (CFDA #12.420), which aims to transform military and public health through innovative biomedical research and investigate medical solutions for battlefield wounds. Over a four-year period from September 2021 through September 2025, Dfci will conduct research to investigate molecular drivers of hyperactive stem cell programs in colorectal cancer and explore potential therapeutic approaches, advancing the program's goals of transforming healthcare and developing medical solutions.

Quick answers

Who received award W81XWH2110383?

W81XWH2110383 was awarded to Dana-Farber Cancer Institute, Inc. by Medical Command (Department of the Army) on September 15, 2021.

How much is award W81XWH2110383 worth?

$1,363,356 has been obligated on W81XWH2110383.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login